Shuyu Zhai

622 total citations
21 papers, 345 citations indexed

About

Shuyu Zhai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shuyu Zhai has authored 21 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Shuyu Zhai's work include Pancreatic and Hepatic Oncology Research (9 papers), RNA modifications and cancer (6 papers) and Pancreatitis Pathology and Treatment (5 papers). Shuyu Zhai is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), RNA modifications and cancer (6 papers) and Pancreatitis Pathology and Treatment (5 papers). Shuyu Zhai collaborates with scholars based in China. Shuyu Zhai's co-authors include Xiaxing Deng, Chenghong Peng, Xinjing Wang, Da Fu, Minmin Shi, Baiyong Shen, Jiancheng Wang, Baiyong Shen, Junjie Xie and Jun Zhang and has published in prestigious journals such as Oncogene, Advanced Science and Cancer Letters.

In The Last Decade

Shuyu Zhai

19 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuyu Zhai China 9 241 213 86 40 37 21 345
Huiming Dong China 6 270 1.1× 233 1.1× 107 1.2× 20 0.5× 38 1.0× 11 361
Jinsei Miyoshi Japan 8 312 1.3× 196 0.9× 76 0.9× 75 1.9× 46 1.2× 17 434
Cunying Ma China 6 288 1.2× 176 0.8× 61 0.7× 42 1.1× 26 0.7× 7 329
Qiangnu Zhang China 12 277 1.1× 217 1.0× 50 0.6× 24 0.6× 65 1.8× 24 372
Jiangnan Qiu China 9 286 1.2× 218 1.0× 36 0.4× 19 0.5× 46 1.2× 13 359
Jinjing Tan China 11 176 0.7× 123 0.6× 104 1.2× 26 0.7× 36 1.0× 28 295
Huajie Zong China 6 219 0.9× 160 0.8× 114 1.3× 42 1.1× 41 1.1× 10 317
Shoumei Yang China 6 225 0.9× 172 0.8× 48 0.6× 29 0.7× 19 0.5× 8 296
Zhongxue Su China 10 183 0.8× 132 0.6× 124 1.4× 66 1.6× 34 0.9× 11 321

Countries citing papers authored by Shuyu Zhai

Since Specialization
Citations

This map shows the geographic impact of Shuyu Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyu Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyu Zhai more than expected).

Fields of papers citing papers by Shuyu Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuyu Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyu Zhai. The network helps show where Shuyu Zhai may publish in the future.

Co-authorship network of co-authors of Shuyu Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Shuyu Zhai. A scholar is included among the top collaborators of Shuyu Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuyu Zhai. Shuyu Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Pengyi, Minmin Shi, Liu Yang, et al.. (2025). Identification of a Novel Small Molecule STING Agonist Reshaping the Immunomicroenvironment of Pancreatic Ductal Adenocarcinoma. International Journal of Biological Sciences. 21(8). 3555–3572.
4.
Gao, Xia, Yang Liu, Shuyu Zhai, et al.. (2024). H19 promotes polarization and alternative splicing in tumor-associated macrophages, facilitating pancreatic cancer progression. Cancer Letters. 611. 217389–217389. 6 indexed citations
5.
Chen, Dongjie, Pengyi Liu, Xiongxiong Lu, et al.. (2024). Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication. Journal of Experimental & Clinical Cancer Research. 43(1). 125–125. 14 indexed citations
6.
Chen, Dongjie, et al.. (2024). A Distinguished Roadmap of Fibroblast Senescence in Predicting Immunotherapy Response and Prognosis Across Human Cancers. Advanced Science. 12(7). e2406624–e2406624. 6 indexed citations
8.
Wang, Xinjing, Xiayang Ying, Shuyu Zhai, et al.. (2023). Hypoxia-induced long non-coding RNA LINC00460 promotes p53 mediated proliferation and metastasis of pancreatic cancer by regulating the miR-4689/UBE2V1 axis and sequestering USP10. International Journal of Medical Sciences. 20(10). 1339–1357. 7 indexed citations
10.
Yang, Liu, Yizhi Cao, Pengyi Liu, et al.. (2023). ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. Cellular Oncology. 47(3). 939–950. 6 indexed citations
11.
Wang, Xinjing, Shuyu Zhai, Minmin Shi, et al.. (2022). Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1. Journal of Hematology & Oncology. 15(1). 128–128. 107 indexed citations
12.
Zhai, Shuyu, Siyi Zou, Zhiwei Xu, et al.. (2021). Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 316–316. 21 indexed citations
13.
Liu, Yuanbin, Zhen Huo, Weishen Wang, et al.. (2020). Construction and integrated analysis of a lncRNA-associated competing endogenous RNA network reveal functional lncRNAs in pancreatic cancer. Translational Cancer Research. 9(5). 3643–3657. 4 indexed citations
14.
Zhai, Shuyu, Zhiwei Xu, Junjie Xie, et al.. (2020). Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1. Oncogene. 40(2). 277–291. 82 indexed citations
15.
Zhai, Shuyu, Zhen Huo, Yue Wang, et al.. (2019). TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. Translational Cancer Research. 8(6). 2416–2424. 6 indexed citations
16.
Zhai, Shuyu, Yuanbin Liu, Xiongxiong Lu, et al.. (2019). <p>INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT</p>. OncoTargets and Therapy. Volume 12. 8287–8299. 13 indexed citations
17.
Zhai, Shuyu, Zhen Huo, Yue Wang, et al.. (2019). TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. Translational Cancer Research. 8(6). 2416–2424. 11 indexed citations
18.
Huo, Zhen, Zhihao Shi, Shuyu Zhai, et al.. (2019). Predicting Selection Preference of Robotic Pancreaticoduodenectomy (RPD) in a Chinese Single Center Population: Development and Assessment of a New Predictive Nomogram. Medical Science Monitor. 25. 8034–8042. 1 indexed citations
20.
Huo, Zhen, Shuyu Zhai, Yuanchi Weng, et al.. (2019). <p>PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis</p>. OncoTargets and Therapy. Volume 12. 5037–5051. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026